Minister reduces forecast and says he should deliver 25.5 million doses of vaccines against Covid in April | Vaccine

Minister reduces forecast and says he should deliver 25.5 million doses of vaccines against Covid in April | Vaccine
Minister reduces forecast and says he should deliver 25.5 million doses of vaccines against Covid in April | Vaccine

“In relation to vaccines, in April, a forecast of 25.5 million doses. There are delays in the delivery of the two main national industries, Butantan and Fiocruz, there is a question of the Indian vaccine, which Anvisa yesterday suspended the plant. So, Covax we have possibility of having 2 million more doses, this estimate is subject to these deliveries that are made to the Ministry of Health, despite being hired, there is a delay in delivery, we are committed to anticipating deliveries, we will seek with all the weapons we have , resources exist, what is lack of vaccine “, said Queiroga.

The problem in the “plant” mentioned by the minister is related to the inspections made by the National Health Surveillance Agency (Anvisa) at the company in India. The agency denied certification of good manufacturing practices to Bharat Biotech, an Indian biotechnology company that developed Covaxin. There were at least 14 points of problems presented in the survey.

This Wednesday (31), Anvisa denied the request to import the 20 million doses of Covaxin, indicating that “there is uncertainty about the efficacy and safety of the vaccine” since data necessary for analysis have not been presented. The Ministry of Health can submit a new request after resolving the documentation problems, according to Anvisa.

The decrease in the total doses already announced for April is not the only setback in the National Immunization Program (PNI). The month of March also ended with a lag in relation to the planning left by General Eduardo Pazuello, who occupied the ministry.

The government predicted 38 million doses from the following manufacturers:

The Indian Covaxin vaccine, produced by Bharat Biotech and imported by the Brazilian Precis Medicamentos, was not delivered. Due to the lack of unsatisfactory documents and information, Anvisa denied import authorization and also did not grant the certificate of good manufacturing practices.

Another reduction occurred in the deliveries of the global consortium Covax Facility, which only delivered just over 1 million doses in its first shipment to the country.

1 of 1 Marcelo Queiroga, Minister of Health, on March 23, 2021 – Photo: Ueslei Marcelino / Reuters

Marcelo Queiroga, Minister of Health, on March 23, 2021 – Photo: Ueslei Marcelino / Reuters

Get the latest news delivered to your inbox

Follow us on social media networks

PREV Ecuadorian girls are thrown over border fence between Mexico and USA – International
NEXT Brazilian Olympic Committee is highlighted on the podium in digital reach